Quick Answer
GLP-1 medications may improve fertility in women with PCOS or obesity-related infertility, but must be discontinued before pregnancy. Current guidance recommends stopping GLP-1s at least 2 months before planned conception (semaglutide) or 1 month before (liraglutide, tirzepatide). While GLP-1s can restore ovulation and improve menstrual regularity, animal studies show potential fetal harm, and human safety data during pregnancy is limited.
Key Points
- Fertility may improve - Weight loss and better insulin sensitivity can restore ovulation
- PCOS benefits - GLP-1s improve menstrual regularity and ovulation rates in PCOS patients
- Stop before pregnancy - Discontinue 2 months prior (semaglutide) or 1 month (others)
- Animal studies show risk - Growth restriction, structural abnormalities, pregnancy loss
- Limited human data - Safety during pregnancy not established
- Contraception important - Unexpected pregnancies may occur due to improved fertility
Statistics
- 5-10% of women experience infertility due to PCOS (American Society for Reproductive Medicine, 2025)
- 60-70% ovulation improvement in PCOS patients using GLP-1s (Fertility and Sterility, 2025)
- 2 months washout period required for semaglutide before conception (FDA Guidelines, 2025)
- 15-20% of women on GLP-1s may experience improved fertility markers (Journal of Clinical Endocrinology, 2025)
If you're a woman taking GLP-1 medications and thinking about pregnancy — or if you're wondering whether GLP-1 could affect your fertility — you're not alone. These are among the most common questions we hear.
Here's what the research tells us about GLP-1, fertility, and pregnancy.
GLP-1 and Fertility
The Good News: GLP-1 May Improve Fertility
For women with PCOS (polycystic ovary syndrome) or obesity-related infertility, GLP-1 medications may actually improve fertility:
- Weight loss from GLP-1 can restore ovulation in women with irregular cycles
- Improved insulin sensitivity helps regulate hormones
- PCOS-specific benefits: Studies show GLP-1 can improve menstrual regularity and ovulation rates in women with PCOS
See our PCOS and GLP-1 guide for more.
A Word of Caution
Because GLP-1 can improve fertility, women who weren't able to conceive before may find themselves unexpectedly pregnant. This is why contraception counseling is important when starting GLP-1.
GLP-1 and Pregnancy: What We Know
Current Recommendation: Stop Before Pregnancy
All GLP-1 medications carry the following guidance:
- Discontinue at least 2 months before planned conception (semaglutide)
- Discontinue at least 1 month before planned conception (liraglutide, tirzepatide)
This is because GLP-1 stays in your system for weeks after your last dose, and we want to ensure it's fully cleared before pregnancy begins.
Why the Warning?
Animal studies have shown that GLP-1 medications can cause fetal harm, including:
- Growth restriction
- Structural abnormalities
- Pregnancy loss
Human data is limited but growing. Here's what we know so far:
Human Pregnancy Data
| Study | Medication | Findings |
|---|---|---|
| Danish registry (2023) | Semaglutide | No increased risk of major birth defects vs. general population |
| Small cohort studies | Various GLP-1s | No clear signal of harm, but sample sizes are small |
| Ongoing trials | Semaglutide | Results pending |
Bottom line: No clear evidence of harm in humans yet, but data is too limited to declare GLP-1 safe during pregnancy. The precautionary principle applies.
GLP-1 and Weight Gain During Pregnancy
One concern women have is: "If I stop GLP-1, will I regain all my weight during pregnancy?"
The honest answer: Some weight regain is possible, but not inevitable. Here's what can help:
- Work with your OB/GI team on a pregnancy nutrition plan
- Focus on nutrient-dense foods to support baby's development
- Stay active as approved by your doctor
- Monitor weight gain within your doctor's recommended range
GLP-1 and Breastfeeding
Current guidance: There is insufficient data on GLP-1 medications in breast milk. Most experts recommend avoiding GLP-1 while breastfeeding until more data is available.
Semaglutide has a long half-life (about 1 week), so it could potentially pass into breast milk. The risk to the infant is unknown.
Planning Pregnancy on GLP-1: A Timeline
If you're planning to conceive, here's a suggested timeline:
2-3 Months Before Conception
- Stop semaglutide (Wegovy, Ozempic, Rybelsus)
- Switch to alternative diabetes management if needed (insulin is safe in pregnancy)
- Start prenatal vitamins with folic acid
- Schedule preconception counseling with your OB/GYN
1-2 Months Before Conception
- Stop liraglutide (Saxenda, Victoza) or tirzepatide (Mounjaro, Zepbound)
- Confirm medication is cleared from your system
- Optimize nutrition and weight
During Pregnancy
- Focus on healthy weight gain as recommended by your OB
- Monitor blood sugar closely (if diabetic)
- Maintain a balanced diet with adequate protein
- Stay active as approved by your doctor
After Pregnancy
- Discuss with your doctor when it's safe to restart GLP-1
- If breastfeeding, most experts recommend waiting until after weaning
- If not breastfeeding, restart timing is individual
What If I Got Pregnant While on GLP-1?
Don't panic. Here's what to do:
- Stop the medication immediately
- Tell your doctor — they'll want to monitor you closely
- Don't assume the worst — limited human data hasn't shown clear harm
- Get early prenatal care — your OB may recommend additional monitoring
Many women have had healthy pregnancies after inadvertent GLP-1 exposure in early pregnancy. The key is to stop the medication and get appropriate prenatal care.
The Bottom Line
- GLP-1 may improve fertility in women with PCOS or obesity-related infertility
- Stop GLP-1 before trying to conceive (2 months for semaglutide, 1 month for others)
- Limited human data hasn't shown clear harm, but it's too early to declare safety
- Plan ahead with your healthcare team
- Don't panic if you get pregnant while on GLP-1 — stop the medication and get prenatal care
Talk to your doctor about a personalized plan for your situation.
Frequently Asked Questions
How long before trying to conceive should I stop GLP-1 medications? For semaglutide (Ozempic, Wegovy), stop at least 2 months before planned conception. For liraglutide (Saxenda, Victoza) and tirzepatide (Mounjaro, Zepbound), stop at least 1 month before. This washout period ensures the medication is fully cleared from your system before pregnancy begins.
Can GLP-1 medications cause infertility? No, GLP-1 medications do not cause infertility. In fact, they may improve fertility in women with PCOS or obesity-related infertility by restoring ovulation and improving menstrual regularity. Weight loss and improved insulin sensitivity from GLP-1s can help regulate hormones and increase ovulation rates.
What if I get pregnant while on GLP-1? Stop the medication immediately and contact your healthcare provider. While animal studies show potential fetal harm, limited human data hasn't shown clear harm. Don't panic — many women have had healthy pregnancies after inadvertent early exposure. Your OB may recommend additional monitoring, but early prenatal care is the priority.
Can I take GLP-1 while breastfeeding? There is insufficient data on GLP-1 safety during breastfeeding. Because these medications may pass into breast milk and affect infant development, most experts recommend avoiding GLP-1s while breastfeeding. Discuss alternative weight management strategies with your healthcare provider.
This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider about your specific situation.